Duke Clinical Research Institute in Durham, N.C., and Vanderbilt University Medical Center in Nashville, Tenn., will collaborate on a study to determine how clinical trials of new drugs and therapies can be conducted more swiftly and efficiently. The new study is backed by a seven-year $26.5 million grant from the National Institutes of Health, according to Duke Today.
"The academic research organization model at the DCRI and Vanderbilt's informatics and central institutional review board model are poised to immediately contribute to the NIH's vision of high-functioning networks for clinical research," said Danny Benjamin MD, PhD, faculty associate director of the DCRI, in Duke Today.
The collaborative effort will consist of three components: the development of protocols and feasible study budgets, creating a review board to expedite the initiation of clinical trials and providing support to researchers from trial inception through the dissemination of results.
Gordon Bernard, MD, director of the Vanderbilt Institute for Clinical and Translational Research, said, "We are excited about the opportunity to be on the ground floor of building a new infrastructure for the efficient conduct of high-quality clinical research that has a major impact on human health."
More articles on quality:
NIH launches largest-ever study of breast cancer risk in black women
HHS improves access to opioid addiction treatment with new actions to fight opioid abuse
CMS overall star ratings have 'several shortcomings,' analysis finds